Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lijuan Ding

Showing results (71-80 of 83) with videos related to

Pageof 9
Sort By:
Cancer Letters|February 21, 2012
K-Ras mutation-mediated IGF-1-induced feedback ERK activation contributes to the rapalog resistance in pancreatic ductal adenocarcinomasFeng Wei, Yan Liu, Anita C Bellail, et al.
Molecular Cancer|July 27, 2017
Exosomes derived from gemcitabine-resistant cells transfer malignant phenotypic traits via delivery of miRNA-222-3pFeng Wei, Chengyuan Ma, Tong Zhou, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 13, 2026
Continuation of First-Line Systemic Therapy with Progression-Directed Radiotherapy in Patients with Oligoprogressive Hepatocellular Carcinoma: A Multicenter, Single-Arm, Phase II TrialFang Shi, Haohua Wang, Yongjing Yang, et al.
Microbial Cell Factories|August 22, 2024
Engineering a non-oxidative glycolysis pathway in escherichia coli for high-level citramalate productionTingting Wang, Lijuan Ding, Huiying Luo, et al.
Frontiers in Oncology|November 18, 2021
Efficacy and Safety of Chimeric Antigen Receptor T Cells in Acute Lymphoblastic Leukemia With Post-Transplant RelapseLijuan Ding, Yiyun Wang, Ruimin Hong, et al.
Clinical Pharmacology in Drug Development|July 3, 2025
A Double-Blind, Placebo-Controlled, Single-Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of HT-101, an RNAi Therapeutic Targeting HBV InfectionJianxiong Zhang, Jiangshuo Li, Le Wu, et al.
International Journal of Radiation Oncology, Biology, Physics|January 17, 2025
Maintaining First-Line Therapy Plus Radiation Therapy May Prolong Progression-Free Survival and Delay Second-Line Therapy for Oligoprogressive Hepatocellular CarcinomaBoyu Leng, Haohua Wang, Yunfan Ge, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|January 15, 2022
Inhibition of Calcium Signaling Prevents Exhaustion and Enhances Anti-Leukemia Efficacy of CAR-T Cells via SOCE-Calcineurin-NFAT and Glycolysis PathwaysMi Shao, Xinyi Teng, Xin Guo, et al.
Nature Aging|July 17, 2024
A metabolic atlas of blood cells in young and aged mice identifies uridine as a metabolite to rejuvenate aged hematopoietic stem cellsXiangjun Zeng, Ce Shi, Yingli Han, et al.
Journal of Hematology & Oncology|July 22, 2021
Dasatinib enhances anti-leukemia efficacy of chimeric antigen receptor T cells by inhibiting cell differentiation and exhaustionHao Zhang, Yongxian Hu, Mi Shao, et al.
Pageof 9

Showing results (71-80 of 83) with videos related to

Sort By:
Pageof 9
Cancer Letters|February 21, 2012
K-Ras mutation-mediated IGF-1-induced feedback ERK activation contributes to the rapalog resistance in pancreatic ductal adenocarcinomasFeng Wei, Yan Liu, Anita C Bellail, et al.
Molecular Cancer|July 27, 2017
Exosomes derived from gemcitabine-resistant cells transfer malignant phenotypic traits via delivery of miRNA-222-3pFeng Wei, Chengyuan Ma, Tong Zhou, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 13, 2026
Continuation of First-Line Systemic Therapy with Progression-Directed Radiotherapy in Patients with Oligoprogressive Hepatocellular Carcinoma: A Multicenter, Single-Arm, Phase II TrialFang Shi, Haohua Wang, Yongjing Yang, et al.
Microbial Cell Factories|August 22, 2024
Engineering a non-oxidative glycolysis pathway in escherichia coli for high-level citramalate productionTingting Wang, Lijuan Ding, Huiying Luo, et al.
Frontiers in Oncology|November 18, 2021
Efficacy and Safety of Chimeric Antigen Receptor T Cells in Acute Lymphoblastic Leukemia With Post-Transplant RelapseLijuan Ding, Yiyun Wang, Ruimin Hong, et al.
Clinical Pharmacology in Drug Development|July 3, 2025
A Double-Blind, Placebo-Controlled, Single-Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of HT-101, an RNAi Therapeutic Targeting HBV InfectionJianxiong Zhang, Jiangshuo Li, Le Wu, et al.
International Journal of Radiation Oncology, Biology, Physics|January 17, 2025
Maintaining First-Line Therapy Plus Radiation Therapy May Prolong Progression-Free Survival and Delay Second-Line Therapy for Oligoprogressive Hepatocellular CarcinomaBoyu Leng, Haohua Wang, Yunfan Ge, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|January 15, 2022
Inhibition of Calcium Signaling Prevents Exhaustion and Enhances Anti-Leukemia Efficacy of CAR-T Cells via SOCE-Calcineurin-NFAT and Glycolysis PathwaysMi Shao, Xinyi Teng, Xin Guo, et al.
Nature Aging|July 17, 2024
A metabolic atlas of blood cells in young and aged mice identifies uridine as a metabolite to rejuvenate aged hematopoietic stem cellsXiangjun Zeng, Ce Shi, Yingli Han, et al.
Journal of Hematology & Oncology|July 22, 2021
Dasatinib enhances anti-leukemia efficacy of chimeric antigen receptor T cells by inhibiting cell differentiation and exhaustionHao Zhang, Yongxian Hu, Mi Shao, et al.
Pageof 9